drugset / Trial / NCT00125736

A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium

NCT00125736

Phase 4 Completed 520 enrolled Eisai Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate the efficacy and safety of combination use of E0671 and Rabeprazole Sodium in patients with gastric ulcer.

Timeline

Start
2005-08-01
Primary completion
2007-04-19
Completion
2007-04-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Teprenone Unknown 50 mg Oral
Background Rabeprazole Small molecule 10 mg Oral

Indications